Explore Before you
decide
We'll send you 30–40 pages spanning the executive summary, methodology, and one regional deep-dive chapter.
Free to access, right away.
REPORT IN CONTEXT
Gene Therapy in CNS Disorder Market: AAV Vector Platforms, Rare Disease Pipelines, and Regulatory Pathway Innovation
PublishedSep 2026
Pages337
Horizon2026-2036
LEAD ANYLYST
AB
Alice BallengerHead of Research · Healthcare